Psychedelics Exceptionalism and Employment-Related Risk in a Clinical Trial

Paper. Dawson L. The American Journal of Bioethics, 18 Sep 2026.

Weekly Science Digest, 19 Sep 2026 to 25 Sep 2026, finding 4: What trial participation costs participants

A bioethics cluster asks whether psychedelic trials adequately disclose employment risk.

The target case is a chronic pain trial; commentaries extend it to military personnel and to whether psychedelics get treated as ethically exceptional. Drug testing, security clearances and licensure can all be jeopardised by documented enrolment.

Read the original

—
Node—
Statuslive
Throughput—